Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nahid Amini

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Nuclear Medicine and Biology|September 27, 2017
[<sup>11</sup>C]AZ10419096 - a full antagonist PET radioligand for imaging brain 5-HT<sub>1B</sub> receptorsAnton Lindberg, Sangram Nag, Magnus Schou, et al.
EJNMMI Research|August 20, 2017
Revisiting the Logan plot to account for non-negligible blood volume in brain tissueMartin Schain, Patrik Fazio, Ladislav Mrzljak, et al.
Neuroimage|July 18, 2016
A human [(11)C]T-773 PET study of PDE10A binding after oral administration of TAK-063, a PDE10A inhibitorAkihiro Takano, Per Stenkrona, Vladimir Stepanov, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 20, 2019
Effect of clinically relevant doses of vortioxetine and citalopram on serotonergic PET markers in the nonhuman primate brainKai-Chun Yang, Vladimir Stepanov, Nahid Amini, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 7, 2016
Characterization of [<sup>11</sup>C]Lu AE92686 as a PET radioligand for phosphodiesterase 10A in the nonhuman primate brainKai-Chun Yang, Vladimir Stepanov, Nahid Amini, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 21, 2015
In Vivo and In Vitro Characterization of a Novel MAO-B Inhibitor Radioligand, 18F-Labeled Deuterated FluorodeprenylSangram Nag, Patrik Fazio, Lutz Lehmann, et al.
Neuroimage|March 4, 2017
Patterns of age related changes for phosphodiesterase type-10A in comparison with dopamine D<sub>2/3</sub> receptors and sub-cortical volumes in the human basal ganglia: A PET study with <sup>18</sup>F-MNI-659 and <sup>11</sup>C-raclopride with correction for partial volume effectPatrik Fazio, Martin Schain, Ladislav Mrzljak, et al.
Molecular Imaging and Biology|September 5, 2013
Synthesis, radiolabeling, and in vivo pharmacokinetic evaluation of the amyloid beta radioligand [11C]AZD4694 in nonhuman primatesMagnus Schou, Katarina Varnäs, Johan Sandell, et al.
Neuropharmacology|January 26, 2017
In vivo measurement of PDE10A enzyme occupancy by positron emission tomography (PET) following single oral dose administration of PF-02545920 in healthy male subjectsMarielle Delnomdedieu, Anton Forsberg, Adam Ogden, et al.
Pharmaceuticals (Basel, Switzerland)|December 31, 2025
Development of <sup>18</sup>F/<sup>11</sup>C-Labeled Pyrrolo-Pyridine/Pyrimidine LRRK2 Selective PET RadioligandsSangram Nag, Vladimir Stepanov, Akihiro Takano, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Nuclear Medicine and Biology|September 27, 2017
[<sup>11</sup>C]AZ10419096 - a full antagonist PET radioligand for imaging brain 5-HT<sub>1B</sub> receptorsAnton Lindberg, Sangram Nag, Magnus Schou, et al.
EJNMMI Research|August 20, 2017
Revisiting the Logan plot to account for non-negligible blood volume in brain tissueMartin Schain, Patrik Fazio, Ladislav Mrzljak, et al.
Neuroimage|July 18, 2016
A human [(11)C]T-773 PET study of PDE10A binding after oral administration of TAK-063, a PDE10A inhibitorAkihiro Takano, Per Stenkrona, Vladimir Stepanov, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 20, 2019
Effect of clinically relevant doses of vortioxetine and citalopram on serotonergic PET markers in the nonhuman primate brainKai-Chun Yang, Vladimir Stepanov, Nahid Amini, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 7, 2016
Characterization of [<sup>11</sup>C]Lu AE92686 as a PET radioligand for phosphodiesterase 10A in the nonhuman primate brainKai-Chun Yang, Vladimir Stepanov, Nahid Amini, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 21, 2015
In Vivo and In Vitro Characterization of a Novel MAO-B Inhibitor Radioligand, 18F-Labeled Deuterated FluorodeprenylSangram Nag, Patrik Fazio, Lutz Lehmann, et al.
Neuroimage|March 4, 2017
Patterns of age related changes for phosphodiesterase type-10A in comparison with dopamine D<sub>2/3</sub> receptors and sub-cortical volumes in the human basal ganglia: A PET study with <sup>18</sup>F-MNI-659 and <sup>11</sup>C-raclopride with correction for partial volume effectPatrik Fazio, Martin Schain, Ladislav Mrzljak, et al.
Molecular Imaging and Biology|September 5, 2013
Synthesis, radiolabeling, and in vivo pharmacokinetic evaluation of the amyloid beta radioligand [11C]AZD4694 in nonhuman primatesMagnus Schou, Katarina Varnäs, Johan Sandell, et al.
Neuropharmacology|January 26, 2017
In vivo measurement of PDE10A enzyme occupancy by positron emission tomography (PET) following single oral dose administration of PF-02545920 in healthy male subjectsMarielle Delnomdedieu, Anton Forsberg, Adam Ogden, et al.
Pharmaceuticals (Basel, Switzerland)|December 31, 2025
Development of <sup>18</sup>F/<sup>11</sup>C-Labeled Pyrrolo-Pyridine/Pyrimidine LRRK2 Selective PET RadioligandsSangram Nag, Vladimir Stepanov, Akihiro Takano, et al.
Pageof 5